BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 10950101)

  • 1. ENT manifestations of gastroesophageal reflux.
    Wong RK; Hanson DG; Waring PJ; Shaw G
    Am J Gastroenterol; 2000 Aug; 95(8 Suppl):S15-22. PubMed ID: 10950101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AGA Clinical Practice Update on the Diagnosis and Management of Extraesophageal Gastroesophageal Reflux Disease: Expert Review.
    Chen JW; Vela MF; Peterson KA; Carlson DA
    Clin Gastroenterol Hepatol; 2023 Jun; 21(6):1414-1421.e3. PubMed ID: 37061897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury.
    Koufman JA
    Laryngoscope; 1991 Apr; 101(4 Pt 2 Suppl 53):1-78. PubMed ID: 1895864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [ENT manifestations of gastroesophageal reflux disease (GERD)].
    Watanabe Y
    Nihon Rinsho; 2004 Aug; 62(8):1533-6. PubMed ID: 15344546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nissen fundoplication surgery for extraesophageal manifestations of gastroesophageal reflux (EER).
    Lindstrom DR; Wallace J; Loehrl TA; Merati AL; Toohill RJ
    Laryngoscope; 2002 Oct; 112(10):1762-5. PubMed ID: 12368611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The relation of GERD, bronchial asthma and the upper respiratory tract].
    Matyásová Z; Novotná B; Matulová M; Dolina J; Kroupa R; Láníková Z; Znojil V; Hep A; Dite P
    Vnitr Lek; 2005 Dec; 51(12):1341-50. PubMed ID: 16430100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ARE THE PERSISTENT SYMPTOMS TO PROTON PUMP INHIBITOR THERAPY DUE TO REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE OR TO OTHER DISORDERS?
    Azzam RS
    Arq Gastroenterol; 2018 Nov; 55Suppl 1(Suppl 1):85-91. PubMed ID: 30304291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Manifestations of gastroesophageal reflux in the otorhinolaryngology tract].
    Issing WJ; Gross M; Tauber S
    Laryngorhinootologie; 2001 Aug; 80(8):464-9. PubMed ID: 11552426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic laryngitis associated with gastroesophageal reflux: prospective assessment of differences in practice patterns between gastroenterologists and ENT physicians.
    Ahmed TF; Khandwala F; Abelson TI; Hicks DM; Richter JE; Milstein C; Vaezi MF
    Am J Gastroenterol; 2006 Mar; 101(3):470-8. PubMed ID: 16542282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application of the recommendations of the conference of consensus in front of symptoms ENT, respiratory or thoracic pains considered as due to a gastroesophageal reflux disease].
    Vallot T; Ducrotte P; Bour B; Jacques JP; Houcke P; De Korwin JD; Pariente A; Aygalenq P; Coudsy B; Carrois F; Ricci L; Bruley des Varannes S
    Presse Med; 2013 May; 42(5):e125-32. PubMed ID: 23414966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of pH probe testing in pediatric patients with extraesophageal manifestations of gastroesophageal reflux disease: a retrospective review.
    Bauman NM; Bishop WP; Sandler AD; Smith RJ
    Ann Otol Rhinol Laryngol Suppl; 2000 Oct; 184():18-24. PubMed ID: 11051426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The otolaryngologic manifestations of gastroesophageal reflux: when is a pH study indicated?
    Bouchard S; Lallier M; Yazbeck S; Bensoussan A
    J Pediatr Surg; 1999 Jul; 34(7):1053-6. PubMed ID: 10442586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of outcome in an open label, therapeutic trial of high-dose omeprazole in laryngitis.
    Williams RB; Szczesniak MM; Maclean JC; Brake HM; Cole IE; Cook IJ
    Am J Gastroenterol; 2004 May; 99(5):777-85. PubMed ID: 15128336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supraesophageal complications of gastroesophageal reflux.
    Hogan WJ; Shaker R
    Dis Mon; 2000 Mar; 46(3):193-232. PubMed ID: 10804898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extra-esophageal gastroesophageal reflux disease and asthma: understanding this interplay.
    Naik RD; Vaezi MF
    Expert Rev Gastroenterol Hepatol; 2015 Jul; 9(7):969-82. PubMed ID: 26067887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastroesophageal reflux disease and the larynx.
    Vaezi MF
    J Clin Gastroenterol; 2003 Mar; 36(3):198-203. PubMed ID: 12590228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Second Canadian Consensus Conference on the Management of Patients with Gastroesophageal Reflux Disease.
    Beck IT; Champion MC; Lemire S; Thomson AB; Anvari M; Armstrong D; Bailey RJ; Barkun AN; Boivin M; Bursey RF; Chaun H; Chiba N; Cockeram AW; Connon JJ; Da Costa LR; Faloon TR; Fedorak RN; Gillies RR; Goeree R; Hunt RH; Inculet RI; Klein A; Leddin DJ; Love JR; Worobetz LJ
    Can J Gastroenterol; 1997 Sep; 11 Suppl B():7B-20B. PubMed ID: 9347173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Empiric trial of high-dose omeprazole in patients with posterior laryngitis: a prospective study.
    Wo JM; Grist WJ; Gussack G; Delgaudio JM; Waring JP
    Am J Gastroenterol; 1997 Dec; 92(12):2160-5. PubMed ID: 9399745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric otolaryngologic manifestations of gastroesophageal reflux disease.
    Gilger MA
    Curr Gastroenterol Rep; 2003 Jun; 5(3):247-52. PubMed ID: 12734048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ear, nose, and throat manifestations of gastroesophageal reflux disease. Complaints can be telltale signs.
    Burton LK; Murray JA; Thompson DM
    Postgrad Med; 2005 Feb; 117(2):39-45. PubMed ID: 15745124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.